Shenzhen Sonosemi Medical Technology Co., Ltd. (referred to as "Sonosemi Medical") is a National High-Tech Enterprise dedicated to provide pan-vascular active diagnosis and interventional solutions. The company is established in April 2020 and headquartered in Shenzhen—China's forefront of technological innovation. As a pioneer in the field, Sonosemi Medical consistently focuses on technological innovation for clinical unmet needs, striving to deliver more sustainable, precise, and safer product solutions.

Driven by a dual-engine model of “clinical insights + technological innovation”, Sonosemi Medical leverages its strong R&D foundation, leading-edge technology, and collaborative ecosystem to accelerate breakthroughs in vascular interventional therapy. By employing an integrated R&D-Production-Commercialization strategy, we have successfully introduced a portfolio of groundbreaking products, including the Coronary Intravascular Lithotripsy System, Intracardiac Echocardiography (ICE) Imaging System, and Peripheral Vascular Lithotripsy System. Through systematical advancement in integrated solutions across the vascular intervention spectrum, Sonosemi Medical enables enhanced clinical outcomes and improved quality of life for patients.